Related Experiment Video
Updated: Mar 9, 2026

Author Spotlight: Advancements in DNA Nanosensors – Addressing Sensitivity and Selectivity Challenges in Molecular Detection
Published on: February 9, 2024
Chemistry-Driven Approaches for Ultrasensitive Nucleic Acid Detection
Sarah J Smith1, Carine R Nemr1, Shana O Kelley1
1Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, §Department of Chemistry, Faculty of Arts and Science, and #Department of Biochemistry, Faculty of Medicine, University of Toronto , Toronto, Ontario M5S 3M2, Canada.
Chemistry-driven methods are advancing nucleic acid sequence analysis for disease diagnosis and treatment. Further innovations are needed to integrate this molecular information into routine clinical medicine for better patient outcomes.
Area of Science:
- Biochemistry and Molecular Biology
- Clinical Diagnostics
- Biotechnology
Background:
- Next-generation sequencing (NGS) generates extensive genetic data, offering insights into disease mechanisms, prognosis, and treatment response.
- Translating this molecular information into clinical utility requires rapid and specific nucleic acid detection methods.
- Current limitations hinder the widespread adoption of genetic analysis in routine medical practice.
Purpose of the Study:
- To discuss chemistry-driven approaches for enhancing DNA and RNA sequence detection in clinical settings.
- To identify unmet needs and future research directions for mainstreaming nucleic acid analysis in medicine.
- To explore the potential of molecular-level information in revolutionizing disease diagnosis and treatment.
Main Methods:
- Review of current chemistry-driven strategies for nucleic acid analysis.
- Discussion of methods enabling rapid genetic information acquisition outside traditional laboratory settings.
- Analysis of challenges and opportunities in developing streamlined nucleic acid detection techniques.
Main Results:
- Emerging chemistry-driven methods show promise for faster and more specific nucleic acid detection.
- Next-generation sequencing provides a foundation for personalized medicine through genetic insights.
- Development of point-of-care or near-patient testing formats is crucial for clinical integration.
Conclusions:
- Chemistry-driven innovations are essential for making nucleic acid analysis a routine clinical tool.
- Overcoming current challenges will enable the use of molecular data for improved disease management.
- Future efforts should focus on developing simple, fast, and clinically applicable nucleic acid detection chemistries.

